Navigation Links
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance
Date:8/5/2014

terest expense; adjust the income tax provision to the estimated amount of taxes that are payable in cash; and adjust for the amount attributable to noncontrolling interests; (v) the adjusted gross margin percentage guidance excludes from estimated GAAP gross margin percentage acquisition accounting inventory fair value step-up adjustments, share-based compensation expense and depreciation expense; (vi) the adjusted SG&A expenses guidance excludes from estimated GAAP SG&A expenses share-based compensation expense, transaction and integration costs and depreciation expense; and (vii) the adjusted R&D expenses guidance excludes from estimated GAAP R&D expenses share-based compensation expense and depreciation expense.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' future financial results, including 2014 financial guidance, the potential for significant financial growth in 2014 and beyond, and other statements that are not historical facts. These forward-looking statements are based on Jazz Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with maintaining and increasing sales of and revenue from Xyrem, such as the potential introduction of generic competition or other sodium oxybate products that compete with Xyrem and changed or increased regulatory restrictions on or requirements with respect to Xyrem, as well as similar risks related to effectively commercializing the company's other marketed products, including Erwinaze and Defitelio; protecting and enhancing the company's intellectual property ri
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
2. Avanir Pharmaceuticals to Participate in Two Conferences in August
3. Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
4. Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
5. Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13
6. Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
7. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
8. Pharmaceuticals Learning the Language of the New Healthcare Landscape
9. Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
10. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
11. Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last month,s ... site now known as the leading online black market ... explosive growth in its offering of drugs and other ... show the takedowns did succeed in lowering the numbers ... review of the markets in August. But some new ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3
... HUNTINGTON BEACH, California and AMSTERDAM, ... diagnostics, announced today that,the US Food and Drug Administration ... ages. MammaPrint is the only FDA-cleared,breast cancer recurrence test ... the FDA has issued four clearances for MammaPrint, covering,all ...
... , SAN DIEGO, Dec. 17 Suneva Medical, a ... signed a multi-million dollar line of credit facility with Western ... be used to fund commercial support for Artefill®, the only ... well as to expand Suneva,s Aesthetic Market growth objectives. , ...
Cached Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 2Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment 3
(Date:12/22/2014)... Coral Gables, FL (PRWEB) December 22, 2014 ... head lice removal service , Lice Troopers, with its new ... established in southern Florida, takes the hassle out of dealing ... removal services in one of their two salon clinic locations ... home or other location. , The decision to expand developed ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The holidays are ... of the season. Many may be thinking about how to ... of a few weeks. Health Republic Insurance of New York ... Dietitian, Andrea Chernus, to provide some smart ideas to enjoy ... healthy. , 1)    Avoid arriving at a holiday gathering over-hungry , ...
(Date:12/22/2014)... Physicians in China are most eagerly ... of non-Hodgkin’s lymphoma (NHL), according to a new report ... consulting firm. MabThera is the only biologic available to ... form of NHL. , According to Kantar Health’s report, ... of NHL in China has been growing and is ...
(Date:12/22/2014)... December 22, 2014 Only weeks following ... and mid-western cities to have a battery manufacturer create ... ( http://www.talklocal.com ) is launching in Henderson ... , “A strong manufacturing sector is going to ... Gurpreet Singh explained, “and TalkLocal works with small businesses ...
(Date:12/22/2014)... Pasadena, CA (PRWEB) December 22, 2014 ... is now offering consultations for sleep apnea. Drowsy drivers ... crashes than drivers who are well-rested, and some experts ... on the roads as intoxicated drivers. Unfortunately, millions of ... to the American Academy of Sleep Medicine, about 18 ...
Breaking Medicine News(10 mins):Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2
... , HOUSTON, Sept. 2 ... new Southeastern U.S. account executive. In her new assignment, ... strategies for clients throughout the region. , , ... for Fortune 500 clients and other corporations through proprietary ...
... , , WASHINGTON, Sept. 2 ... in Detroit to participating in a conspiracy to defraud the Medicare ... U.S. Attorney Terrence Berg of the Eastern District of Michigan and ... Human Services (HHS) announced. , , Vargas-Arias, ...
... , , , ... COLUMBIA, Md., Sept. 2 Martek Biosciences Corporation (Nasdaq: MATK ) ... for the third quarter were $77.8 million, down 12% from $88.4 million in ... per diluted share, for the third quarter of fiscal 2009, a 4% decrease ...
... ATLANTA, Sept. 2 /PRNewswire-FirstCall/ -- Gentiva Health Services, ... home health services, announced today that it has completed its acquisition ... of the Rush Health System, located in central Mississippi and west ... , , "We extend a warm welcome to ...
... , , ABBOTT PARK, ... ABT ) announced today a definitive agreement to acquire Visiogen, Inc. ... accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients. ... company based in Irvine, Calif., with European operations in Karlsruhe, Germany, ...
... , , , ... Center (SRC) held its first benefit, dessert and silent ... SRC Founder, Jennifer Hoffiz, said, "The concert was well attended and ... and the silent auction allow SRC to offer 3 or 4 ...
Cached Medicine News:Health News:Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 2Health News:Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 3Health News:Martek Announces Third Quarter 2009 Financial Results 2Health News:Martek Announces Third Quarter 2009 Financial Results 3Health News:Martek Announces Third Quarter 2009 Financial Results 4Health News:Martek Announces Third Quarter 2009 Financial Results 5Health News:Martek Announces Third Quarter 2009 Financial Results 6Health News:Martek Announces Third Quarter 2009 Financial Results 7Health News:Martek Announces Third Quarter 2009 Financial Results 8Health News:Martek Announces Third Quarter 2009 Financial Results 9Health News:Martek Announces Third Quarter 2009 Financial Results 10Health News:Martek Announces Third Quarter 2009 Financial Results 11Health News:Martek Announces Third Quarter 2009 Financial Results 12Health News:Gentiva(R) Health Services Completes Acquisition of Home Health Agency 2Health News:Gentiva(R) Health Services Completes Acquisition of Home Health Agency 3Health News:Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 2Health News:Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 3Health News:Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 4Health News:Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 5Health News:Sensory Research Center Benefit Concert Yields Scholarships for Autistic Children 2
... Medtronic's OctoBase Retractor system ... median sternotomy beating heart CAB ... allows countless Octopus stabilizer mounting ... design allows for multiple blade ...
... lift the heart - Guidant's third generation ... XPOSE 3 is designed to securely lift ... to easily position and access target vessels ... and non-apical placement on the heart, this ...
... The VASOVIEW 5 system is ... (EVH) system designed to minimize the ... with traditional harvesting procedures. Incorporating an ... controls to eliminate operative obstructions, this ...
... PTVA ( Percutaneous Transseptal Ventricular ... for the hemodynamic needs of patients for ... Surgeons. These specialists have historically used ... artery perfusion, but the IABP provides minimal ...
Medicine Products: